This compound is primarily used in peptide synthesis, particularly in solid-phase peptide synthesis (SPPS) techniques. It serves as a building block for introducing fluorinated amino acids into peptide chains, which can enhance the stability, bioavailability, and binding affinity of the resulting peptides. The Fmoc group protects the amino acid during synthesis, allowing for selective deprotection and coupling steps. Its incorporation is valuable in drug discovery and development, especially for creating peptide-based therapeutics with improved pharmacokinetic properties. Additionally, it is used in research to study the effects of fluorination on peptide structure and function.